Private Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Hold
620
0.02% 166
2026
Q1
$218K Sell
620
-100
-14% -$35.6K 0.02% 160
2025
Q4
$236K Sell
720
-150
-17% -$47.6K 0.02% 155
2025
Q3
$246K Sell
870
-66
-7% -$19.1K 0.02% 151
2025
Q2
$261K Buy
936
+107
+13% +$30.3K 0.02% 147
2025
Q1
$258K Buy
+829
New +$245K 0.02% 145
2024
Q4
Sell
-2,749
Closed -$886K 172
2024
Q3
$886K Buy
2,749
+1,450
+112% +$474K 0.07% 94
2024
Q2
$406K Buy
1,299
+300
+30% +$88.1K 0.03% 125
2024
Q1
$284K Sell
999
-2,406
-71% -$704K 0.02% 139
2023
Q4
$981K Buy
3,405
+15
+0.4% +$4.09K 0.08% 88
2023
Q3
$911K Hold
3,390
0.09% 85
2023
Q2
$753K Sell
3,390
-27
-0.8% -$6.26K 0.07% 93
2023
Q1
$826K Buy
+3,417
New +$839K 0.08% 91
2014
Q4
Sell
-3,608
Closed -$507K 147
2014
Q3
$507K Buy
+3,608
New +$471K 0.11% 126
2014
Q1
Sell
-4,000
Closed -$456K 157
2013
Q4
$456K Hold
4,000
0.1% 129
2013
Q3
$448K Hold
4,000
0.11% 128
2013
Q2
$395K Buy
+4,000
New +$415K 0.1% 127

Other funds holding AMGN

Private Wealth Partners's AMGN Position: Q2 2026 in Review

Private Wealth Partners held its Amgen (AMGN) position steady in Q2 2026 at 620 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #166.

Private Wealth Partners first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. The position peaked at $981K in Q4 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Private Wealth Partners held 620 shares of Amgen worth $225K as of Q2 2026.
  • Private Wealth Partners left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.02% of Private Wealth Partners's portfolio in Q2 2026, its #166 holding.
  • Private Wealth Partners first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
  • Private Wealth Partners's Amgen position peaked at $981K in Q4 2023.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Private Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.